APPLICATIONS FOR THE ACTUATOR JULY COHORT ARE NOW OPEN!
Utilising a 15-month focused industry-led curriculum, The Actuator Accelerator Program will take Seed ventures to Series A investment; leading into clinical trials, advanced manufacturing, and at-scale technology deployment. Through intensive mentorship, industry collaboration, and value-network support, our startups can achieve in 15 months what can typically take 3 years or more.
The Actuator will admit 20+ start-ups into the Accelerator Program annually through two rounds (February and July), and with the support from corporate partners, prepare them for future capital raisings, clinical trials and market launch. Milestone momentum is rewarded with multiple capital injection points and the program is tightly linked to startup pathways across the globe. The expected outcome is a globally competitive medtech company that has raised $2.7M+ in Angel and Series A round funding, and is well underway in their clinical trials.
This initiative has received funding through the MTPConnect Project Fund Program—a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sector. MTPConnect is supported by the Australian Government Industry Growth Centres Initiative. Learn more at mtpconnect.org.au.
The Actuator is a spin-out of STC Australia—one of Australia’s longest-lived advanced technology incubators.
The Actuator is made possible through collaboration across our ecosystem partners who have come together to create Australia’s economic and healthcare future.
Our special thanks go to our partners and sponsors: MTP Connect, the Federal Government, STC Australia, the Victorian State Government, Artesian, EY, Johnson & Johnson, Medtronic, Cook Medical, MTAA, Baker Heart and Diabetes Institute, Burnet Institute, Macquarie University, Swinburne University, University of Melbourne, K&L Gates, Medical Intelligence, MiniFAB, Planet Innovation, Invetech, Tiller Design, Cobalt Design, Entech Electronics, Amatek Design, Procept, Hydrix, EXA Product Development, Outerspace Design, Design+Industry, Tricycle Developments, Blue Curve, Brandwood Biomedical, Truly Deeply, Innermaven, EsicHub, Dialectica Group, Melbourne Angels, Sydney Angels, Mobius Medical, Jared Roache Design, Foundersuite, Australian Healthcare Solutions, F2F Communications, BioMelbourne Network, Cogentum, GrantReady, and Science in Public.
HOW TO APPLY
Applications for the next round are open until 27 April 2018 for participation in the program from 9 July 2018 – 1 October 2019.
Applications must be by an Australian company incorporated within the previous five years, be based on intellectual property (i.e. patents), be on a regulated pathway (e.g. TGA) and hardware-based (i.e. diagnostic, bionics, device, instrumentation, digital health and services).
Visit our application form.